Altshuler Shaham LTD Supernus Pharmaceuticals, Inc. Transaction History

Altshuler Shaham LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$34.93 - $42.03 $31,541 - $37,953	-903 Reduced 52.99%	801 $29,000
Q4 2022 May 09, 2023	SELL	$31.09 - $37.88 $1,709 - $2,083	-55 Reduced 3.13%	1,704 $60,000
Q3 2022 Nov 14, 2022	BUY	$28.79 - $35.41 $50,641 - $62,286	1,759 New	1,759 $59,000
Q2 2022 Aug 10, 2022	SELL	$25.33 - $34.25 $32,245 - $43,600	-1,273 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$28.51 - $32.9 $36,293 - $41,881	1,273 New	1,273 $41,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.